TECARTUS

Product NDC
71287-220
11-digit product format
712870220
Labeler code
71287
Product ID
71287-220_16fbe9a0-d7d4-43b1-aa67-3c16ff8c5f55
Type
CELLULAR THERAPY
Nonproprietary name
brexucabtagene autoleucel
Dosage form
SUSPENSION
Route
INTRAVENOUS
Labeler
Kite Pharma, Inc.
Application
BLA125703
Marketing category
BLA
Marketing start
2021-10-01
Substance
BREXUCABTAGENE AUTOLEUCEL
Active strength
1000000 1/68mL
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TECARTUSBREXUCABTAGENE AUTOLEUCELKite Pharma, Inc.a16108c2-7ca7-45af-965e-54bda47130222026-06-16Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA125703
ndc (product): 71287-220

Additional Listing Data#

Finished product
Yes
Brand name base
TECARTUS
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BREXUCABTAGENE AUTOLEUCEL1000000 1/68mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4MD2J2T8SJInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2387347Internal RxNorm lookup
2387352Internal RxNorm lookup
2572002Internal RxNorm lookup
2572005Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
a16108c2-7ca7-45af-965e-54bda4713022Available on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71287-220-01TECARTUS68 mL in 1 BAGSUSPENSION6816
71287-220-02TECARTUS1 in 1 PACKAGESUSPENSION116

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71287-220-01EA - Each71287-2208fd9bcff-3c1b-4720-b28b-fcaadc68e0c512021-11-09
71287-220-02EA - Each71287-22025e54ed8-ef75-420e-bad7-d7ad7e8d790b12021-11-09

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71287-220TECARTUS (BREXUCABTAGENE AUTOLEUCEL) SUSPENSION [KITE PHARMA, INC.]12Current NDC, Legacy NDC, 2 package rows20240627_a16108c2-7ca7-45af-965e-54bda4713022.zip

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125703TecartusBrexucabtagene Autoleucel351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2572002brexucabtagene autoleucel 100,000,000 CELLS per 68 ML InjectionPSNa16108c2-7ca7-45af-965e-54bda471302216
2387347brexucabtagene autoleucel 200,000,000 CELLS in 68 ML InjectionPSNa16108c2-7ca7-45af-965e-54bda471302216
2572005Tecartus 100,000,000 CELLS in 68 ML InjectionPSNa16108c2-7ca7-45af-965e-54bda471302216
2387352Tecartus 200,000,000 CELLS in 68 ML InjectionPSNa16108c2-7ca7-45af-965e-54bda471302216
257200568 ML brexucabtagene autoleucel 1471000 CELLS/ML Injection [Tecartus]SBDa16108c2-7ca7-45af-965e-54bda471302216
238735268 ML brexucabtagene autoleucel 2940000 CELLS/ML Injection [Tecartus]SBDa16108c2-7ca7-45af-965e-54bda471302216
257200268 ML brexucabtagene autoleucel 1471000 CELLS/ML InjectionSCDa16108c2-7ca7-45af-965e-54bda471302216
238734768 ML brexucabtagene autoleucel 2940000 CELLS/ML InjectionSCDa16108c2-7ca7-45af-965e-54bda471302216
257200568 ML Tecartus 1471000 CELLS/ML InjectionSYa16108c2-7ca7-45af-965e-54bda471302216
238735268 ML Tecartus 2940000 CELLS/ML InjectionSYa16108c2-7ca7-45af-965e-54bda471302216
2572002brexucabtagene autoleucel 100,000,000 CELLS per 68 ML InjectionSYa16108c2-7ca7-45af-965e-54bda471302216
2387347brexucabtagene autoleucel 200,000,000 CELLS per 68 ML InjectionSYa16108c2-7ca7-45af-965e-54bda471302216
2572005Tecartus 100,000,000 CELLS per 68 ML InjectionSYa16108c2-7ca7-45af-965e-54bda471302216
2387352Tecartus 200,000,000 CELLS per 68 ML InjectionSYa16108c2-7ca7-45af-965e-54bda471302216

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71287-220-017128702200168 mL in 1 BAG68 mlHistorical
71287-220-02712870220021 BAG in 1 PACKAGE (71287-220-02) / 68 mL in 1 BAG (71287-220-01) 1 bag2021-10-010000-00-00NoNoCurrent